Saturday 17 October 2026 Export ANIP’s income statement to Excel — free account

ANI Pharmaceuticals, Inc.

ANIP Healthcare Drug Manufacturers Specialty & Generic

ANI Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $883.4 million, up 43.8% from fiscal 2024. In the quarter to June 2026, revenue grew 25.9%, EPS grew 194.6%, free cash flow fell 22.2% and total debt fell 1.78%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.

72.08 0.20 −0.28%

Follow ANIP

Alert me

Market cap: $1.7B
P/E: 14.9×
Fwd P/E: 14.5×
Dividend yield: —
F-score: 7/9
Altman Z: 2.30
Beneish M: −2.62
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	8.56%	16.34%	18.63%	20.88%
Piotroski F-Score Full definition →		7	7	8	7
ROA Full definition →		2.89%	5.66%	6.73%	7.61%
ROIC Full definition →		5.26%	8.05%	9.10%	11.30%
Return on Tangible Assets Full definition →		7.94%	14.36%	15.90%	17.56%
Average Days of Receivables Full definition →		111.51	116.14	100.93	102.40
Free Cash Flow per Share Full definition →		6.74	7.53	8.74	7.92
Free Cash Flow Full definition →		135.32	150.90	182.81	167.52
Capital Expenditures Full definition →		(35.40)	(34.32)	(25.80)	(21.94)
Other line items
Cash ROIC Full definition →		9.68%	10.39%	12.17%	10.58%
Accounts Receivable Turnover Full definition →		3.68	3.51	3.88	3.91
Accounts Payable Turnover Full definition →		4.92	6.31	5.90	6.03
Inventory Turnover Full definition →		2.18	2.44	2.58	2.75
Average Days of Payables Full definition →		79.28	66.93	70.30	69.56
Days of Inventory on Hand Full definition →		166.39	153.00	144.71	134.87
Tax Rate Full definition →		(0.20)	(0.18)	(0.21)	(0.24)
Research and Development Expense of Revenue Full definition →		6.78%	5.85%	5.60%	5.10%
Selling, General and Administrative Expense of Revenue Full definition →		36.85%	35.97%	34.09%	33.19%
Share Based Compensation of Revenue Full definition →		4.26%	4.29%	4.25%	4.20%
Interest Coverage Full definition →		3.32	5.54	6.75	9.09
Operating CF/Net income Full definition →		4.38	2.40	2.28	1.75
Depreciation/Fixed assets Full definition →		1.60	1.46	1.33	1.17
Capex/Depreciation Full definition →		(0.35)	(0.38)	(0.29)	(0.26)
Revenue per Share Full definition →		41.19	44.05	44.17	46.24
Operating CF per Share Full definition →		8.50	9.24	9.97	8.95
Capex per Share Full definition →		(1.76)	(1.71)	(1.23)	(1.04)
Capex to Sales Full definition →		0.04	0.04	0.03	0.02

Show all line items

Columns are period end dates

Stockrow Weekly